CIS by Deloitte Blog 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties; Further Delay of Effective Date

On Friday, May 19, 2017, the Health Resources and Services Administration (HRSA) posted an update that further delayed the effective date of the final rule published in the Federal Register (82 FR 1210, (January 5, 2017)) titled '340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation', from May 22, 2017 to the... Read MoreThe post 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties; Further Delay of Effective Date appeared first on CIS by Deloitte | Compliance. Performance. Experience.